POSACONAZOLE — NEW AZOLE BROAD-SPECTRUM ANTIFUNGAL AGENT FOR PREVENTION AND TREATMENT OF INVASIVE MYCOSES
Invasive mycoses are a common complication of various categories of immune depressed patients that are characterized with heavy clinical presentations and high lethal rate. Many causatives of invasive mycoses are resistant to currently applied antifungal medications, and some are polybresistant. Pos...
Saved in:
Main Author: | N.N. Klimko |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2008-04-01
|
Series: | Вопросы современной педиатрии |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/1374 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structure of Pathogens Causing Invasive Mycoses and the Development of Their Resistance to Antifungal Drugs
by: A. V. Avtonomova, et al.
Published: (2025-04-01) -
Comparative pharmacoeconomic analysis of posaconazole therapy in tablet form and in suspension for invasive fungal infections prevention
by: I. S. Krysanov, et al.
Published: (2021-06-01) -
Intravenous posaconazole: key features of clinical pharmacology and practical applications
by: A. V. Veselov, et al.
Published: (2022-04-01) -
THE PROBLEM OF INVASIVE MYCOSES IN RHEUMATOLOGY(Part I)
by: Boris Sergeyevich Belov, et al.
Published: (2009-12-01) -
Comparative clinical and economic analysis of pozaconazol (Noxafil) for invasive mycoses (IM) prevention in patients with severe neutropenia during treatment of acute myeloid leukemia or myelodysplastic syndrome
by: I. S. Krysanov, et al.
Published: (2019-04-01)